Skip to content
DraconiticResearch
Search Sources API
186,125 studies31 sourcesUpdated 51 min ago
Peer-reviewedPublisher termsDiabetes, Obesity, and Cardiometabolic CARE

RAAS Inhibitors for the Primary Prevention of CKD in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-analysis

  • Raveendhara R. Bannuru1,2,3,4,5
  • Katherine Fazioli1
  • Ian H. de Boer6
  • Amy Earley7
  • Nuha A. ElSayed1,2,4,5,8
  • Paola Fioretto9
  • Kamlesh Khunti10
  • Sankar D. Navaneethan11,12
  • Meredith Noble1
  • Caroline Richardson13
  • Sylvia E. Rosas2,14
  • Peter Rossing15,16
5 more authors
  • Shylaja Srinivasan17
  • Katherine R. Tuttle18
  • Deborah J. Wexler2,19
  • Nicole M. Bhave20
  • Joshua J. Neumiller21
21 affiliations
  1. 1American Diabetes Association, Arlington, VA
  2. 2Harvard Medical School, Boston, MA
  3. 3Tufts University School of Medicine, Boston, MA
  4. 4Diabetes Education For All (DEFA) Foundation, New York, NY
  5. 5Supercharged Scientific, Wellesley, MA
  6. 6Kidney Research Institute and Department of Medicine, University of Washington, Seattle, WA
  7. 7Kidney Disease: Improving Global Outcomes, Brussels, Belgium
  8. 8Brigham and Women’s Hospital, Boston, MA
  9. 9Department of Medicine, University of Padova, Padova, Italy
  10. 10Diabetes Research Centre, University of Leicester, Leicester, U.K.
  11. 11Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX
  12. 12Renal Section, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX
  13. 13Brown University, Providence, RI
  14. 14Joslin Diabetes Center, Boston, MA
  15. 15Steno Diabetes Center Copenhagen, Copenhagen, Denmark
  16. 16University of Copenhagen, Copenhagen, Denmark
  17. 17University of California, San Francisco, CA
  18. 18University of Washington, Spokane, WA
  19. 19Massachusetts General Hospital Diabetes Center, Boston, MA
  20. 20Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Health, Ann Arbor, MI
  21. 21College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA
Read full textDOICite

Related

  1. SGLT2 Inhibitors for the Primary Prevention of CKD in Type 2 Diabetes: A Systematic Review and Meta-analysis
    Raveendhara R. Bannuru, Katherine Fazioli, Nicole M. Bhave +14
    Diabetes, Obesity, and Cardiometabolic CAREPeer-reviewedPublisher termsFull textEndocrinology & metabolismPMC
  2. PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trials
    P.-M. Morice, I. Ray-Coquard, K.N. Moore +2
    Annals of OncologyPeer-reviewedLicence not statedFull text8 citedOncologyHAL
  3. Oral Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Ischemic Stroke or High‐Risk Transient Ischemic Attack: Systematic Review and Meta‐Analysis
    Mirza Ammar Arshad, Hina Nadeem, Maham Afzal +9
    Brain and behaviorPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCDOAJ
  4. Severe Infection Outcomes With SGLT2 Versus DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active-Comparator Meta-Analysis of Real-World Cohorts.
    Yung-Ming Huang, Jen-Hung Wang, Wan-Ting Huang +2
    Endocrinology, diabetes & metabolismPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMC
  5. Gene‐Guided Therapy in Type 2 Diabetes Mellitus: An Integrative Review of the Pharmacogenetics of Metformin and Sodium‐Glucose Cotransporter‐2 Inhibitors
    Imran Hossain, Mahnoor Haidar, Mahfuj Ahmed Ratul +4
    Endocrinology, diabetes & metabolismPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC

Cite

BibTeXRIS
BibTeX
@article{bannuru2026raas,
  title = {{RAAS Inhibitors for the Primary Prevention of CKD in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-analysis}},
  author = {Raveendhara R. Bannuru and Katherine Fazioli and Ian H. de Boer and Amy Earley and Nuha A. ElSayed and Paola Fioretto and Kamlesh Khunti and Sankar D. Navaneethan and Meredith Noble and Caroline Richardson and Sylvia E. Rosas and Peter Rossing and Shylaja Srinivasan and Katherine R. Tuttle and Deborah J. Wexler and Nicole M. Bhave and Joshua J. Neumiller},
  journal = {Diabetes, Obesity, and Cardiometabolic CARE},
  year = {2026},
  month = jun,
  doi = {10.2337/doci25-0014},
  url = {https://doi.org/10.2337/doci25-0014},
}
RIS
TY  - JOUR
TI  - RAAS Inhibitors for the Primary Prevention of CKD in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-analysis
AU  - Raveendhara R. Bannuru
AU  - Katherine Fazioli
AU  - Ian H. de Boer
AU  - Amy Earley
AU  - Nuha A. ElSayed
AU  - Paola Fioretto
AU  - Kamlesh Khunti
AU  - Sankar D. Navaneethan
AU  - Meredith Noble
AU  - Caroline Richardson
AU  - Sylvia E. Rosas
AU  - Peter Rossing
AU  - Shylaja Srinivasan
AU  - Katherine R. Tuttle
AU  - Deborah J. Wexler
AU  - Nicole M. Bhave
AU  - Joshua J. Neumiller
PY  - 2026
DA  - 2026/06/26
JO  - Diabetes, Obesity, and Cardiometabolic CARE
DO  - 10.2337/doci25-0014
UR  - https://doi.org/10.2337/doci25-0014
SN  - 3067-3518
SN  - 3067-3534
ER  -